Canada Markets closed

Eyenovia, Inc. (EYEN)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
3.5000-0.1000 (-2.78%)
At close: 04:00PM EST
3.4700 -0.03 (-0.86%)
After hours: 05:50PM EST
Full screen
Trade prices are not sourced from all markets
Previous Close3.6000
Open3.5700
Bid3.4600 x 1800
Ask3.5200 x 800
Day's Range3.4850 - 3.5950
52 Week Range3.3100 - 7.7200
Volume59,823
Avg. Volume393,019
Market Cap99.426M
Beta (5Y Monthly)2.00
PE Ratio (TTM)N/A
EPS (TTM)-0.7820
Earnings DateMar. 23, 2022 - Mar. 28, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est12.50
  • Simply Wall St.

    Eyenovia (NASDAQ:EYEN) investors are sitting on a loss of 12% if they invested a year ago

    The simplest way to benefit from a rising market is to buy an index fund. But if you buy individual stocks, you can do...

  • Zacks

    Eyenovia, Inc. (EYEN) Reports Q3 Loss, Misses Revenue Estimates

    Eyenovia, Inc. (EYEN) delivered earnings and revenue surprises of 11.54% and -100.00%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

  • GlobeNewswire

    Eyenovia Reports Third Quarter 2021 Financial Results

    On track with VISION-2 phase 3 presbyopia trial and expedited resubmission of MydCombi™ New Drug Application as a drug/device combination in early 2022 Current cash resources anticipated to be sufficient to cover MydCombi NDA resubmission, completion of Phase 3 MicroLine program, and completion of manufacturing facility Company to host conference call and webcast tomorrow, November 11, at 5:00pm ET NEW YORK, Nov. 10, 2021 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophtha